Cardiorenal syndrome in COVID-19

Ali, Uzair Akbar; Sadiq, Muhammad Sajjad; Yunus, Muhammad Jawad

doi:10.1136/bcr-2021-241914

Cited by 5 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…COVID-19 has the potential to affect all body systems. The most frequently reported symptoms of COVID-19 are high-grade fever, cough with expectoration, and dyspnea ( Ali, Sadiq & Yunus, 2021 ; Cabrera Martimbianco et al, 2021 ; Piazza et al, 2020 ; Rubino et al, 2020 ; Tian et al, 2020 ; Verdecchia et al, 2020 ; Wild et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

The long-term effects of COVID-19 on pulmonary status and quality of life

Alahmari,

Krishna,

Jose

et al. 2023

PeerJ

View full text Add to dashboard Cite

Background Few studies have looked at how SARS-CoV-2 affects pulmonary function, exercise capacity, and health-related quality of life over time. The purpose of this study was to evaluate these characteristics in post COVID-19 subjects 1 year after recovery. Methods The study included two groups. The case group included post COVID-19 subjects who had recovered after a year, and the control group included healthy participants who had never tested positive for COVID-19. Results The study screened 90 participants, 42 of whom met the eligibility criteria. The findings revealed that the majority of post COVID-19 subjects had relatively normal lung function 1-year post-recovery. A significant reduction in DLCO (B/P%) was observed in the case group vs. control. The exercise capacity test revealed a clinically significant difference in distance walked and a significant difference in the dyspnea post-walk test in the case group compared to the control group. The case group’s health-related quality of life domain scores were significantly affected in terms of energy/fatigue, general health, and physical function. Conclusions The post COVID-19 subjects were shown to have well-preserved lung function after 1 year. However, some degree of impairment in diffusion capacity, exercise capacity, and health-related quality of life remained.

show abstract

Section: Introductionmentioning

confidence: 99%

The long-term effects of COVID-19 on pulmonary status and quality of life

Alahmari,

Krishna,

Jose

et al. 2023

PeerJ

View full text Add to dashboard Cite

show abstract

Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism

Umesh

Pranay

Pandey³

et al. 2022

Infection

View full text Add to dashboard Cite

Purpose Apart from the global disease burden of acute COVID-19 disease, the health complications arising after recovery have been recognized as a long-COVID or post-COVID-19 syndrome. Evidences of long-COVID symptoms involving various organ systems are rapidly growing in literature. The objective was to perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms. Methods Publications reporting clinical trials, observational cohort studies, case–control studies, case-series, meta-analysis, and systematic reviews, focusing on the squeal of the disease, consequences of COVID-19 treatment/hospitalization, long-COVID, chronic COVID syndrome, and post acute COVID-19 were reviewed in detail for the narrative synthesis of frequency, duration, risk factors, and pathophysiology. Results The review highlights that pulmonary, neuro-psychological, and cardiovascular complications are major findings in most epidemiological studies. However, dysfunctional gastrointestinal, endocrine, and metabolic health are recent findings for which underlying pathophysiological mechanisms are poorly understood. Analysis of the clinical trial landscape suggests that more than 50% of the industry-sponsored trials are focused on pulmonary symptoms. In contrast to the epidemiological trends and academic trials, cardiovascular complications are not a focus of industry-sponsored trials, suggestive of the gaps in the research efforts. Conclusion The gap in epidemiological trends and academic trials, particularly concerning cardiovascular complications not being a focus of industry-sponsored trials is suggestive of the gaps in research efforts and longer follow-up durations would help identify other long-COVID-related health issues such as reproductive health and fertility. Supplementary Information The online version contains supplementary material available at 10.1007/s15010-022-01835-6.

show abstract

Comparación de las manifestaciones oculares durante el contagio por COVID-19 y después de la vacunación

Serrano

Mendoza

Pacheco

et al. 2023

Cienc. Tecnol. Salud Vis. Ocul.

View full text Add to dashboard Cite

El objetivo del presente estudio es identificar la frecuencia de manifestaciones sistémicas y oculares en pacientes diagnosticados con COVID-19, y analizar los síntomas asociados a la vacunación. Como metodología, se diseñó un cuestionario de 15 preguntas sobre manifestaciones oculares asociadas a la SARS-CoV-2 y síntomas tras la vacunación. Se realizó un análisis descriptivo, incluyendo el uso de porcentajes y frecuencias para variables cualitativas. Se realizaron análisis bivariados según la relación existentes entre las variables de interés. En el estudio participaron 270 personas en los siguientes porcentajes según edad: menores de 18 años, 10,7 % (29 personas); de 18 a 30 años, 85,6 % (231 personas); de 31 a 40 años, 3,3 % (9 personas), y mayores de 41 años, 0,4 % (1 persona). De ellos, el 29,3 % (79 personas) fue diagnosticado con SARS-CoV-2. Las manifestaciones generales y oculares se evaluaron en una escala de 0 a 4, en la que 1 correspondía a síntomas leves, y 4 a síntomas incapacitantes. La pérdida del olfato y del gusto fue relatada como incapacitante en el 7,03 % (19 personas) de los casos, seguida de cefalea en el 5,18 % (14 personas) de los casos. En cuanto a las manifestaciones oculares, el dolor ocular obtuvo un porcentaje del 4,44 % (12 personas) en la escala 3, seguido de la sensibilidad a la luz en un 6,29 % (17 personas) en la escala 2. Los síntomas oculares reportados se presentaron principalmente entre 1 a 3 días en un 12,6 % (34 personas) de los casos. El 95,6 % (258 personas) de los encuestados estaba vacunado contra el SARS-CoV-2. En cuanto a los síntomas sistémicos más frecuentemente reportados como incapacitantes después de la vacunación, se observó dolor de cabeza en el 8,5 % (23 personas) de los casos, seguido de dolor muscular en el 8,1 % (22 personas) de los casos. Dentro de las manifestaciones oculares, predominó el prurito en un 1,4 % (4 personas) de los casos, seguido de la sequedad ocular en un 1,1 % (3 personas) de los casos. Estas manifestaciones se presentaron principalmente entre 1 a 3 días después de la vacunación en el 40 % (108 personas) de los participantes. Como conclusiones, si bien la vacunación contra el SARS-CoV-2 ha sido efectiva, persisten casos positivos en los que los síntomas reportados con mayor frecuencia han sido la pérdida del olfato y del gusto, el dolor de cabeza y la secreción nasal; además, se ha informado dolor ocular incapacitante. En cuanto a los síntomas presentados después de la vacunación, se destacan el dolor muscular, el dolor de cabeza y el picor de ojos.

show abstract

Cardiorenal syndrome in COVID-19

Cited by 5 publications

References 17 publications

The long-term effects of COVID-19 on pulmonary status and quality of life

The long-term effects of COVID-19 on pulmonary status and quality of life

Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism

Comparación de las manifestaciones oculares durante el contagio por COVID-19 y después de la vacunación

Contact Info

Product

Resources

About